Lisa Peterson

Mayo Clinic — United States

Medicine · Health Sciences

10h-index402citations32works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Venous Thromboembolism Diagnosis and Management(18), Atrial Fibrillation Management and Outcomes(10), Central Venous Catheters and Hemodialysis(6), Acute Myocardial Infarction Research(4), Uterine Myomas and Treatments(4)

Publications32 total

Evaluation of extended direct oral anticoagulant dosing strategies in patients with and without cancer from a prospective observational registry
Research and Practice in Thrombosis and Haemostasis·2025· 2 citedOpen Access
The impact of a primary aldosteronism predictive model in secondary hypertension decision support
JAMIA Open·2024Open Access
The Impact of a Primary Aldosteronism Predictive Model in Secondary Hypertension Decision Support
2024Open Access
Extended Full Dose Versus Low Dose Direct Oral Anticoagulants in Cancer and Overweight Patients
Blood·2023· 3 cited
Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism
Thrombosis Research·2022· 16 cited
Incidental pulmonary embolism in cancer and noncancer patients: Prospective cohort study
European Journal Of Haematology·2022· 8 cited
Single versus multiple and incidental versus symptomatic subsegmental pulmonary embolism: clinical characteristics and outcome
Journal of Thrombosis and Thrombolysis·2022· 8 cited
Outcomes of Patients with Extended Anticoagulation Using Low Dose Doacs Compared to Standard Therapeutic Anticoagulation
Blood·2021· 1 cited
Evaluation of Changing Vena Cava Filter Use and Inpatient Hospital Mortality from 2016-2019: A Single-Institution Quality Improvement Project
Mayo Clinic Proceedings Innovations Quality & Outcomes·2021· 2 citedOpen Access
Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism
Mayo Clinic Proceedings·2021· 38 cited
Demographics and Clinical Outcomes in Patients Older Than 75 Years Treated for Acute Venous Thromboembolism
American Journal of Therapeutics·2021
Association between Cancer and Anatomical Site of Venous Thromboembolic Disease
Blood·2020
Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweight
European Journal Of Haematology·2020· 20 cited
Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism
Mayo Clinic Proceedings Innovations Quality & Outcomes·2020· 10 citedOpen Access
Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban
American Journal of Hematology·2020· 33 citedOpen Access
Treatment of Upper Extremity Deep Vein Thrombosis with Apixaban and Rivaroxaban
Blood·2019· 6 cited
Incidental Pulmonary Embolism. Analysis of Mayo Clinic Venous Thromboembolism Database
Blood·2019· 1 cited
Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer‐associated venous thromboembolism
American Journal of Hematology·2019· 72 citedOpen Access
1143: IMPACT OF OBESITY ON VENTILATOR-ASSOCIATED EVENTS
Critical Care Medicine·2018· 1 cited
Cancer-Associated Thrombosis and Bleeding Risk in Gastrointestinal Malignancies with Apixaban and Rivaroxaban Compared to Low Molecular Weight Heparin
Blood·2018· 2 cited
page 1 of 2Next →

Frequent Co-authors

Damon E. Houghton(17), Robert D. McBane(17), Waldemar E. Wysokiński(16), Ana I. Casanegra(16), David O. Hodge(16), Danielle T. Vlazny(15), David A. Froehling(13), Gina K. Hesley(5), Dalene Bott‐Kitslaar(4), David A. Woodrum(4), Amy L. Weaver(4), Phyllis C. Leppert(4), Elizabeth A. Stewart(4), Krzysztof R. Gorny(4), Ryan A. Meverden(4), Teresa Lang(4), Emily Barnard(3), Ahmed M. Abdelmagied(3), Lisa E. Vaughan(3), Vanessa L. Jacoby(3)